FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69416
Company■ Unclear/unknown
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi
KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 12:00 UTC
LAST UPDATE2026-10-07 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Completed Phase 3 vaccine results posted; relevant only to sponsor pipeline, not broad market.
Clinical update with narrow relevance
CATALYST TO WATCH
Regulatory submission decision
MAIN RISK
Results may not support approval
FULL DISPATCH
Sponsor: Sanofi; Status: Completed; Conditions: Meningococcal Immunisation, Healthy Volunteers; Interventions: MenACYW conjugate vaccine, MenACYW conjugate vaccine; Enrollment: 840 (actual); First posted: 2024-02-29; Results posted: 2026-10-07; NCT: NCT06284915
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Breast Cancer Awareness Month Raises Questions About Antipsychotic Drug Warnings2026-10-07 15:46 UTC
Breast Cancer Awareness Month Raises Questions About Antipsychotic Drug Warnings2026-10-07 15:46 UTC
→CORRELATIONshares Healthcare
MNA Brigham and Women's Hospital Nurses and Mass General Brigham to Negotiate on October 8 Ahead of Potential October 14 Indefinite Strike2026-10-07 15:48 UTC
MNA Brigham and Women's Hospital Nurses and Mass General Brigham to Negotiate on October 8 Ahead of Potential October 14 Indefinite Strike2026-10-07 15:48 UTC
→CORRELATIONshares Healthcare
Primary Partners Alliance Demonstrates Nearly $70 Lower PMPM Healthcare Costs Using Lightbeam Health Solutions2026-10-07 16:02 UTC
Primary Partners Alliance Demonstrates Nearly $70 Lower PMPM Healthcare Costs Using Lightbeam Health Solutions2026-10-07 16:02 UTC
→CORRELATIONshares Healthcare
Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs2026-10-07 16:15 UTC
Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs2026-10-07 16:15 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.